Indian J Pharm Close
 

Table 1: Efficacy outcomes before and after matching baseline criteria. Note that Major Molecular Response and overall survival is significantly greater for nilotinib as compared to dasatinib. Adopted from Signorovitch et al.[2]

Table 1: Efficacy outcomes before and after matching baseline criteria. Note that Major Molecular Response and overall survival is significantly greater for nilotinib as compared to dasatinib. Adopted from Signorovitch <i>et al.</i><sup>[2]</sup>